Vol 2, No 1 (2016)

Table of Contents

Full Issue

AMOR Volume 2, Issue 1: Full Issue
 
222 Views
PDF

Editorials

Personalized hormonal treatment for prostate cancer: An opportunity for improvement
Omar Abdel-Rahman
940 Views
PDF
1

Reviews

Tenosynovial Giant Cell Tumor: Better molecular understanding revolutionizes treatment outcome
Emad Shash
968 Views
PDF
2-4
Non-coding RNAs: New therapeutic targets and opportunities for hepatocellular carcinoma
Yu Cuiyun, Qian Ning, Zhi-Ping Li, Wen Huang, Jia Yu, Xiao-Yan Yang, Xiao-Yong Lei
1354 Views
PDF
5-17
Pharmacometrics and systems pharmacology of immune checkpoint inhibitor nivolumab in cancer translational medicine
Sujit Nair
2588 Views
PDF
18-31

Case Reports

Is indocyanine green angiography a reliable tool for the assessment of venous congestion in muscle flaps?
Jon Ver Halen, Bahar Abbassi
12641 Views
PDF
32-35
An interesting pathological diagnosis: Angiosarcoma of breast
Sachin Bhalchandra Ingle, Datta Dhondigir Girji
624 Views
PDF
36-38

Original Research Articles

An epidemiological analysis of benign pelvic tumors
Tao Jin, Wei-Feng Liu, Zhi-Ping Deng, Yuan Li, Xiao-Hui Niu
723 Views
PDF
39-44
Evaluation of cervicovaginal smear results at postmenopausal period
Sefa Kelekci, Emre Destegül, Servet Gençdal, Emre Ekmekçi, Hüseyin Aydoğmuş, Orçun Özdemir
801 Views
PDF
45-49
One thousand patients with symptomatic aortic valve disease and malignancy: Can they withstand aortic valve replacement?
Wilhelm Peter Mistiaen
549 Views
PDF
50-56
Lysophosphatidic acid receptor isoforms expression in prostate cancer cells is differentially regulated by the CYP17A1 inhibitor abiraterone and depends on the androgen receptor
Matthias B Stope, Robert Mandelkow, Daniela Brunnert, Martin Weiss, Martin Burchardt
1683 Views
PDF
57-62